Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
RESEARCH TOOLSreports
Holding CGTX?
Track your performance easily
CGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.34 - $2.95
Previous Close$0.44
Volume83.36K
Average Volume (3M)494.30K
Market Cap
$17.87M
Enterprise Value-$3.16M
Total Cash (Recent Filing)$22.01M
Total Debt (Recent Filing)$580.00K
Price to Earnings (P/E)―
Beta2.71
Next Earnings
Mar 26, 2025EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.96
Shares Outstanding41,547,995
10 Day Avg. Volume399,799
30 Day Avg. Volume494,299
Standard Deviation0.27
R-Squared0.06
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)1.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.08
Forecast
1Y Price Target
$5.00Price Target Upside1062.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Cognition Therapeutics News
PremiumCompany Announcements
Cognition Therapeutics Reports Promising Q3 2024 Results
PremiumPre-Earnings
Is CGTX a Buy, Before Earnings?
PremiumCompany Announcements
Cognition Therapeutics Highlights CT1812 Potential in CNS Disorders
PremiumCompany Announcements
Cognition Therapeutics Shares Investor Presentation UpdateOwnership Overview
30.54% Insiders
3.50% Mutual Funds
3.81% Other Institutional Investors
59.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CGTX FAQ
What was Cognition Therapeutics’s price range in the past 12 months?
Cognition Therapeutics lowest stock price was $0.34 and its highest was $2.95 in the past 12 months.
What is Cognition Therapeutics’s market cap?
Currently, no data Available
When is Cognition Therapeutics’s upcoming earnings report date?
Cognition Therapeutics’s upcoming earnings report date is Mar 26, 2025 which is in 123 days.
How were Cognition Therapeutics’s earnings last quarter?
Cognition Therapeutics released its earnings results on Nov 13, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.197 by -$0.053.
Is Cognition Therapeutics overvalued?
According to Wall Street analysts Cognition Therapeutics’s price is currently Undervalued.
Does Cognition Therapeutics pay dividends?
Cognition Therapeutics does not currently pay dividends.
What is Cognition Therapeutics’s EPS estimate?
Cognition Therapeutics’s EPS estimate is -$0.21.
How many shares outstanding does Cognition Therapeutics have?
Cognition Therapeutics has 41,547,997 shares outstanding.
What happened to Cognition Therapeutics’s price movement after its last earnings report?
Cognition Therapeutics reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.197. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Cognition Therapeutics?
Among the largest hedge funds holding Cognition Therapeutics’s share is Carlson Capital LP. It holds Cognition Therapeutics’s shares valued at N/A.
---
Cognition Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (1062.52% Upside)
$5.00 (1062.52% Upside)
Blogger Sentiment
Bearish
CGTX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 140.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.8%
Last 30 Days ▲ 25.0%
Last 30 Days ▲ 25.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.10%
12-Months-Change
Fundamentals
Return on Equity
-157.90%
Trailing 12-Months
Asset Growth
-28.87%
Trailing 12-Months
Company Description
Cognition Therapeutics
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
---
CGTX Earnings Call
Q2 2024
0:00 / 0:00
---
CGTX Stock 12 Month Forecast
Average Price Target
$5.00
▲(1062.52% Upside)
Technical Analysis
Best Analysts Covering CGTX
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-46.35%
reiterated a buy rating 19 days ago
Copying Jay Olson's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -46.35% per trade.
---